@article { author = {Vyas, Ashish and Varma, Vishwanath and Garg, Garima and Gupta, Priyal and Trehanpati, Nirupma}, title = {The role and delicate balance of Host Immunity in Coronavirus Disease-19}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {1-12}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.88526.1874}, abstract = {Severe Acute Respiratory Syndrome (SARS) associated with SARS-CoV-2, causes a severe form of the respiratory illness known as Coronavirus Disease-19 (COVID-19). COVID-19 has emerged as a worldwide pandemic with a high number of fatalities. Approximately 112,654,202 people have been infected so far with this disease which has led to the death of more than one point seven million (2,496,749) till 24th Feb, 2021. Measures to counter this disease have led to a global economic slowdown. Multiple drug trials are ongoing and several putative candidates for vaccination against the virus have been approved and are in the pipeline. Many studies have also characterized the immunological profile of patients infected with COVID-19. Some studies suggest that the severity of the COVID-19 infection is directly associated with the cytokine storm. In this review, we aim to compile the available knowledge and describe the nature of immune responses in patients infected with COVID-19 in different age groups, comorbidity, and immune-compromised state and their association with disease severity.}, keywords = {COVID-19,Immune response,COVID-19 Infection,Immune Cells}, url = {https://iji.sums.ac.ir/article_47385.html}, eprint = {https://iji.sums.ac.ir/article_47385_0c20a634c1c00dd1a7e71961e1c4f444.pdf} } @article { author = {Mansourabadi, Amir Hossein and Sadeghalvad, Mona and Mohammadimotlagh, Hamid-Reza and Amirzargar, Aliakbar}, title = {Serological and Molecular Tests for COVID-19: a recent update}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {13-33}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.88660.1894}, abstract = {The COVID-19 pandemic is probably the most devastating worldwide challenge in recent century. COVID-19 leads to a mild to severe respiratory disease and affects different organs and has become a global concern since December 2019. Meanwhile, molecular biology and diagnostic laboratories played an essential role in diagnosis of the disease by introducing serological and molecular tests. Molecular-based techniques are reliable detection tools for SARS-CoV-2 and used for diagnosis of patients especially in the early stage of the disease. While, serological assays are considered as additional tools to verify the asymptomatic infections, tracing previous contacts of individuals, vaccine efficacy, and study the seroprevalance. The average time of the appearance of anti-SARS-CoV-2 antibodies in the patient's serum is 3-6 days after the onset of symptoms for both IgM and IgA and 10-18 days for IgG. Following the outbreak of COVID-19, FDA has approved and authorized a series of serological laboratory tests for early diagnosis. Serological assays have low-cost and provide fast results but have poor sensitivity in the early stage of the viral infection. Although the serological tests may not play an important role in the active case of COVID-19, it could be effective to determine the immunity of health care workers, and confirm late COVID-19 cases during the outbreak. In this review, we compared various laboratory diagnostic assays for COVID-19.}, keywords = {COVID-19,Laboratory Diagnosis Tests,PCR,SARS-CoV-2,Serological Assays}, url = {https://iji.sums.ac.ir/article_47386.html}, eprint = {https://iji.sums.ac.ir/article_47386_056e26e76c7e7e8b957949f4d9887dcc.pdf} } @article { author = {Fathi, Mobina and Vakili, Kimia and Sayehmiri, Fatemeh and Mohamadkhani, Ashraf and Ghanbari, Reza and Hajiesmaeili, Mohammadreza and Rezaei-Tavirani, Mostafa}, title = {Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {34-46}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.87723.1824}, abstract = {Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new global health threat. Objectives: To analyze the effectiveness of the measurement of specific antibodies to SARS-CoV2 (IgM and IgG) for the diagnosis of COVID-19 and to analyze the rate of SARS-CoV2 seroprevalence in the population. Methods: 11 relevant studies, published before June 5, 2020, were included in this meta-analysis. These studies were identified by searching the MEDLINE and Scopus databases. The final selected studies were analyzed using STATA version 14. Publication bias was examined using both Egger's test and Funnel plots. Moreover, the I² statistic has been used to evaluate and verify heterogeneity. Results: The 11 relevant studies selected for the present meta-analysis cover a total of 996 infection cases. According to the results, the average rate of positive cases for IgM (AU/mL) was 2.10 (95% CI: 1.65-2.55; I2=92.2%), and the sensitivity in individuals with positive IgM test was 63% (95% CI: 47-79; I2=94.9%). In addition, the average rate of positive cases for IgG (AU/mL) was 67.44 (95% CI: 28.79-106.09; I2=99.4%), and the sensitivity in individuals with positive IgG test was 79% (95% CI: 67-90; I2=89.5%). Conclusions: According to this analysis, detection of anti-SARS-CoV-2 IgM and IgG antibodies may assist early detection of SARS-CoV2 infection. Whether antibodies against SARS-CoV-2 confer protective immunity warrants further studies.}, keywords = {Antibody,IgG,IgM,rRT-PCR}, url = {https://iji.sums.ac.ir/article_47466.html}, eprint = {https://iji.sums.ac.ir/article_47466_d3db40baa4594d66584027b81394f547.pdf} } @article { author = {Hassani, Danesh and Amiri, Mohammad Mehdi and Maghsood, Faezeh and Salimi, Vahid and Kardar, Gholam Ali and Barati, Omid and Hashemian, Seyed Mohammad Reza and Jeddi-Tehrani, Mahmood and Zarnani, Amir-Hassan and Shokri, Fazel}, title = {Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {47-53}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.87990.1843}, abstract = {Background: Incidence and severity of SARS-CoV2 infection are significantly lower in children and teenagers proposing that certain vaccines, routinely administered to neonates and children may provide cross-protection against this emerging infection. Objective: To assess the cross-protection induced by prior measles, mumps and rubella (MMR) vaccinations against COVID-19. Methods: The antibody responses to MMR and tetanus vaccines were determined in 53 patients affected with SARS-CoV2 infection and 52 age-matched healthy subjects. Serum levels of antibodies specific for NP and RBD of SARS-CoV2 were also determined in both groups of subjects with ELISA. Results: Our results revealed significant differences in anti-NP (p <0.0001) and anti-RBD (p <0.0001) IgG levels between patients and healthy controls. While the levels of rubella- and mumps specific IgG were not different in the two groups of subjects, measles-specific IgG was significantly higher in patients (p <0.01). The serum titer of anti-tetanus antibody, however, was significantly lower in patients compared to healthy individuals (p <0.01). Conclusion: Our findings suggest that measles vaccination triggers those B cells cross-reactive with SARS-CoV2 antigens leading to the production of increased levels of measles-specific antibody.}, keywords = {Antibody Response,Cross-protection,MMR,SARS-CoV2,Tetanus}, url = {https://iji.sums.ac.ir/article_47467.html}, eprint = {https://iji.sums.ac.ir/article_47467_2866f9f848db52c513482a08052f27a2.pdf} } @article { author = {Taghiloo, Saeid and Soltanshahi, Mohsen and Aliyali, Masoud and Abedi, Siavash and Mehravaran, Hossein and Ajami, Abolghasem and Asgarian-Omran, Hossein}, title = {Cytokine profiling in Iranian patients with COVID-19; association with clinical severity}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {54-64}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.87630.1810}, abstract = {Background: SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is recognized for the first time in Wuhan, China. The cytokine storm is a known factor causing major clinical symptoms leading to death in COVID-19 patients. Objective: To investigate and compare the serum levels of different cytokines in COVID-19 patients with different clinical severity. Methods: Concentrations of serum cytokines, including IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, IFN-γ, and GM-CSF, were measured in 61 COVID-19 patients and 31 normal controls with ELISA. We investigated the correlation between the levels of these cytokines and clinical severity, CRP level, neutrophil and lymphocyte count in patients with COVID-19. Results: Our data indicated that the levels of IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α, IFN-γ, and GM-CSF, but not IL-10 were significantly increased in COVID-19 patients compared to normal controls. Statistical analysis showed that the level of IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α, IFN-γ, and GM-CSF were higher in severe COVID-19 than those of mild cases. The concentrations of all mentioned cytokines were negatively associated with the absolute count of lymphocytes, and positively correlated with the CRP level and the absolute count of neutrophils. Conclusion: The current study suggests that high levels of various cytokines correlate with the disease severity and immunopathogenesis of COVID-19.}, keywords = {COVID-19,Cytokine storm,disease severity,Iran}, url = {https://iji.sums.ac.ir/article_47468.html}, eprint = {https://iji.sums.ac.ir/article_47468_82e9e14287b741084a96e432dce45fd4.pdf} } @article { author = {Bagheri-Hosseinabadi, Zahra and Ostad Ebrahim, Hamid and Bahrehmand, Fatemeh and Taghipour, Gholamhosein and Abbasifard, Mitra}, title = {The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {65-73}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.88780.1904}, abstract = {Background: The role of cytokine storm in the immunopathogenesis of coronavirus disease 2019 (COVID-19) has been implicated. Objective: To determine the association of microRNA (miRNA)-10b and serum levels of IL-2 and IL-8 in patients with COVID-19. Methods: Blood samples were obtained from 33 COVID-19 patients and 29 healthy subjects. After RNA extraction and cDNA synthesis, the transcript level of miR-10b was determined by Real-time PCR. In addition, the serum levels of IL-2 and IL-8 were measured in subjects using ELISA. Results: The patient group comprised of 33 patients with COVID-19 (62.4 ± 3.7 years old), 13 (39%) males and 20 (61%) females. In the control group, 29 subjects (56.6 ± 1.6 years old), 9 (31%) males and 20 (69%) females, were included. The expression of miR-10b was significantly downregulated in the peripheral blood of COVID-19 patients in comparison to the healthy controls (fold change= 0.12, p < 0.0001). The levels of IL-2 (p < 0.001) and IL-8 (p < 0.001) were significantly increased in the serum samples of COVID-19 patients compared to the healthy subjects. The expression level of miR-10b was correlated significantly with the serum levels of IL-2 and IL-8 as well as with the age of patients, ESR and CRP levels. Conclusions: miR-10b is downregulated in the COVID-19 patients and might result in increased levels of IL-2 and IL-8, hence contributing to cytokine storm.}, keywords = {Coronavirus disease 2019,MicroRNA,Cytokine storm,IL-2,IL-18}, url = {https://iji.sums.ac.ir/article_47469.html}, eprint = {https://iji.sums.ac.ir/article_47469_9b261b1243b514da8784e6361549be56.pdf} } @article { author = {Jandaghi, Elahe and Hemati, Maral and Mohammadlou, Maryam and Jandaghi, Jafar and Mirmohammadkhani, Majid and Danaei, Navid and Kokhaei, Parviz}, title = {Prevalence of COVID-19 Virus Infection in Semnan province}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {74-81}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.87670.1826}, abstract = {Background: Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) causing a human pandemic disease named COVID-19 has become a major global health concern. Iran as one of the most affected countries needs unprecedented effort for monitoring and evaluation of COVID-19. Objective: To determine the seroprevalance of COVID-19 in Semnan province North-East of Iran. Methods: Six hundred people were randomly selected using the "SIB data-base". From 1 to 30 June, 2020, 153 participants of Semnan population were enrolled. Blood, nasopharyngeal and oropharyngeal samples were obtained. Prevalence of IgM and IgG antibodies were ascertained using ELISA and Real-Time PCR was conducted to evaluate viral load. Estimates of prevalence were standardized by age and sex, based on the 2015 national census of Semnan province. Results: Seroprevalence showed no difference between females and males and no significant association between age and seropositivity. Among total participants, the age and sex adjusted prevalence of SARS-CoV2 infection was 19.3% (95% CI, 14.0-26.7 per 100 persons). Approximately 10% of participants had detectable antibodies but showed a negative-PCR result. However, approximately 80% of participants did not show an evidence of infection. Conclusion: The majority of the population in Semnan province has no detectable antibodies to SARS-CoV-2. Therefore, Semnan is considered a SARS-CoV-2 susceptible area. These results emphasize the need for maintaining public health measures to tackle the new epidemic wave.}, keywords = {Antibody Response,Immunoglobulin,SARS-CoV-2,Serology,prevalence}, url = {https://iji.sums.ac.ir/article_47470.html}, eprint = {https://iji.sums.ac.ir/article_47470_d39c555e00515c357422611ba3ac76e9.pdf} } @article { author = {Mortezagholi, Sahar and Rostamzadeh, Davood and Alinejad, Maedeh and Younesi, Vahid and Tabarsi, Payam and Shabani, Mahdi}, title = {Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {82-92}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.88168.1851}, abstract = {Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly transmits in general population, mainly between health-care workers (HCWs) who are in close contact with patients. Objective: To study the seropositivity of HCWs as a high-risk group compared to general population. Methods: 72 samples were obtained from HCWs working in Masih Daneshvari hospital as one of the main COVID-19 admission centers in Tehran, during April 4 to 6, 2020. Also we collected 2021 blood samples from general population. The SARS-CoV-2 specific IgM, and IgG antibodies in the collected serum specimens were measured by commercial ELISA kits. Results: Based on the clinical manifestations, 25.0%, 47.2%, and 27.8% of HCWs were categorized as symptomatic with typical symptoms, symptomatic with atypical symptoms, and asymptomatic, respectively. Symptomatic individuals with typical and atypical symptoms were 63.2% and 36.8% positive in RT-PCR test, respectively. Anti-SARS-CoV-2 IgM and IgG antibodies were detected in 15.3% and 27.8% of HCWs samples, respectively. Antibody testing in the general population indicated that SARS-CoV-2 specific IgM and IgG were found in (162/2021) 8%, and (290/2021) 14.4%, respectively. The frequency of positive cases of IgM and IgG were significantly increased in HCWs compared to general population (p= 0.028 for IgM and p= 0.002 for IgG). Conclusion: The frequency of SARS-CoV-2 specific antibodies in HCWs was higher than general population indicating a higher viral transmission via close exposure with COVID-19 patients.}, keywords = {COVID-19,ELISA,general population,health-care workers,SARS-CoV-2,Seroprevalence}, url = {https://iji.sums.ac.ir/article_47471.html}, eprint = {https://iji.sums.ac.ir/article_47471_37e1dfb68d88e845ac91b684bc6c56c1.pdf} } @article { author = {Alikhani, Mehrdad and Javadi, Amir and Aalikhani, Mahdi}, title = {Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19}, journal = {Iranian Journal of Immunology}, volume = {18}, number = {1}, pages = {93-94}, year = {2021}, publisher = {Shiraz Institute for Cancer Research}, issn = {1735-1383}, eissn = {1735-367X}, doi = {10.22034/iji.2021.89684.1962}, abstract = {}, keywords = {COVID-19,Bradykinin,Cytokines}, url = {https://iji.sums.ac.ir/article_47472.html}, eprint = {https://iji.sums.ac.ir/article_47472_0bfb741b9e664638967a1635376a84f5.pdf} }